Mon-07-03-2016, 23:54 PM
|
AbbVie and Boehringer Ingelheim to develop and commercialize BI 655066
|
|
« Next Oldest | Next Newest »
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
|
AbbVie to take Nimbles IL23R for psoriasis | Fred | 12 | 5,761 |
Wed-18-12-2024, 15:04 PM Last Post: Fred |
|
|
Obese children more likely to develop psoriasis | Fred | 2 | 2,241 |
Thu-22-08-2024, 19:53 PM Last Post: Fred |
|
|
AbbVie will present data on risankizumab at EADV | Fred | 3 | 7,291 |
Mon-26-09-2016, 17:07 PM Last Post: jiml |
|
|
Psoriasis clear 66 months after one subcutaneous injection of trial drug BI 655066 | Fred | 11 | 20,290 |
Tue-08-03-2016, 19:10 PM Last Post: D Foster |
|
|
New psoriasis treatment BI 655066 worked faster than Stelara | Fred | 3 | 6,970 |
Thu-08-10-2015, 13:48 PM Last Post: jiml |
Users browsing this thread: 1 Guest(s)


Health Boards